Onconetix (ONCO) vs PRF Technologies (PRFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Onconetix is the larger company by market cap ($3.9 million vs $3.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ONCO | PRFX |
|---|---|---|
| Share price | $0.7363 | $0.8667 |
| Market cap | $3.86M | $3.03M |
| 1-day change | +23.29% | -1.25% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $310.39 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $209.50 | $7.95 |
| 52-week low | $0.58 | $0.852 |
| Distance from 52-week high | -99.65% | -89.10% |
| Average volume | 2.23M | 298.86K |
| Shares outstanding | 5.24M | 3.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ONCO vs PRFX FAQ
Which is bigger, Onconetix or PRF Technologies?
Onconetix (ONCO) is larger, with a market capitalization of $3.86M compared with $3.03M for PRF Technologies (PRFX).
Are Onconetix and PRF Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.